Nasdaq

Haemonetics Receives FDA Clearance For NexSys PCS® With Persona™ Technology

BOSTON, Oct. 2, 2020 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative hematology solutions to drive better patient outcomes, ...
MassDevice

Haemonetics gets FDA nod for next-gen plasma collection system

Haemonetics (NYSE: HAE) announced that it received FDA approval for its NexSys PCS plasma collection system with Persona PLUS ...
Seeking Alpha

Haemonetics Receives FDA Clearance for Enhancements to NexSys PCS® Plasma Collection System

BOSTON, June 22, 2023 /PRNewswire/ -- Haemonetics Corporation (HAE), a global medical technology company focused on delivering innovative solutions to drive better patient outcomes, today announced it ...
Business Insider

Haemonetics Announces Regulatory Clearances of NexSys PCS™ Enhanced Software with YES™ Technology

BRAINTREE, Massachusetts, March 28, 2018 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for enhancement of its ...
Morningstar

Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology

BOSTON, Feb. 23, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today ...
The Herald-Dispatch

Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements in this press release may include, without ...